References
- Ryder N S. Terbinafine: Mode of action and properties of the squalene epoxidase inhibition. Br J Dermatol 1992; 126(suppl 39)2–7
- Petranyi G, Meingassner J G, Mieth H. Antifungal activity of the allylamine derivative terbinafine in vitro. Antimicrob Agents Chemother 1987; 31: 1365–8
- Clayton Y M. In-vitro activity of terbinafine. Clin Exp Dermatol 1989; 14: 101–3
- Frain-Bell W. Chronic paronychia. Trans St John's Hosp Dermatol Soc 1957; 38: 29–33
- Stone O J, Mullins J F, Head E S. Chronic paronychia: Occupational material. Arch Environ Health 1964; 9: 585–8
- Roberts D T. Paronychia. Superficial fungal infections, J Verbov. MTP Press, Lancaster 1986; 39–45
- Hay R J, Clayton Y M. The treatment of patients with chronic rnucocutaneous candidosis and Candida onychomycosis with ketoconazole. Clin Exp Demtol 1982; 7: 155–62
- Hay R J, Baran R, Moore M K, et al. Candida onychornycosis -an evaluation of the role of Candida species in nail disease. Br J Dermatol 1988; 118: 47–58